Pharmacological advantages are a key driver to alternative drug delivery dosage forms like transdermal or topical patches. These alternative drug delivery systems form an important part of the current global pharmaceutical market by addressing differing patient profiles and needs. Increasingly pharma companies and patients are looking at innovative and diverse drug delivery methods to reach the needs of a wider demographic population. Transdermal patches or TTS (Transdermal Therapeutic Systems) for systemic or local active topical drug delivery are an important sphere of drug delivery, one which should be considered alongside more traditional methods of delivery such as oral or parenteral. TTS provide a wide range of benefits which include easy self-administration; minimal pain levels; constant infusion-type delivery; avoidance of hepatic first-pass effect; reduced side effects; and dose reduction due to an increased bioavailability, amongst others.
This webinar will discuss the characteristics and advantages of TTS, to better/alternatively administer pharmaceutical actives. The webinar will also inform about new computerized prediction tools and their use to assess the feasibility to utilize TTS for the first-time development of patches, next generation or generic products; and show the results of such in different case studies. The webinar will also give an outlook on what is coming next in transdermal drug delivery.
This webinar shall offer a first access into the transdermal drug delivery space and give an insight into the opportunities for the pharmaceutical industry.
Key Learning Objectives
- Understand the potential of transdermal therapeutic systems (TTS) in the pharmaceutical industry.
- Learn about the rational development approach by combination of in vitro and in silico methods
- Learn about the formulation and manufacturing approaches for the development of new or generic transdermal systems for a systemic or local drug delivery
Target Audience
- Drug Delivery Scientists
- R&D
- Formulation Pharmacist
- Head of Pharmaceutical Technology
- Director
- Formulation Development
- Product Development
- Innovation Technology
- Business Development
- Procurement
